Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.

Neuropsychiatry

McGuire JF, Lewin AB, Geller DA, Brown A, Ramsey K, Mutch J, Mittelman A, Micco J, Jordan C, Wilhelm S, Murphy TK, Small BJ, Storch EA.
PMID: 24174993
Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38.

Exposure-based cognitive-behavioral therapy and serotonin reuptake inhibitor medications are efficacious treatment options for the management of pediatric obsessive-compulsive disorder. Despite established efficacy, many youths receiving either therapy remain symptomatic after acute treatment. Regardless of the rationale for persistent symptoms,...

Cite
McGuire JF, Lewin AB, Geller DA, et al. Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry (London). 2012;2(4)doi: 10.2217/npy.12.38.
McGuire, J. F., Lewin, A. B., Geller, D. A., Brown, A., Ramsey, K., Mutch, J., Mittelman, A., Micco, J., Jordan, C., Wilhelm, S., Murphy, T. K., Small, B. J., & Storch, E. A. (2012). Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry, 2(4), . https://doi.org/10.2217/npy.12.38
McGuire, Joseph F, et al. "Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention." Neuropsychiatry vol. 2,4 (2012). doi: https://doi.org/10.2217/npy.12.38
McGuire JF, Lewin AB, Geller DA, Brown A, Ramsey K, Mutch J, Mittelman A, Micco J, Jordan C, Wilhelm S, Murphy TK, Small BJ, Storch EA. Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38. PMID: 24174993; PMCID: PMC3808983.
Copy Download .nbib Format: NLM
Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention.

Neuropsychiatry

Tandon N, Shah J, Keshavan MS, Tandon R.
PMID: 23125875
Neuropsychiatry (London). 2012;2(4):345-353. doi: 10.2217/npy.12.36.

Recent efforts in the prevention of schizophrenia have focused on defining psychosis-risk syndromes and evaluating treatments that can prevent transition to psychosis in these ultra-high risk groups. In this review, different kinds of prevention approaches are enumerated and necessary...

Cite
Tandon N, Shah J, Keshavan MS, et al. Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. Neuropsychiatry (London). 2012;2(4):345-353doi: 10.2217/npy.12.36.
Tandon, N., Shah, J., Keshavan, M. S., & Tandon, R. (2012). Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. Neuropsychiatry, 2(4), 345-353. https://doi.org/10.2217/npy.12.36
Tandon, Neeraj, et al. "Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention." Neuropsychiatry vol. 2,4 (2012): 345-353. doi: https://doi.org/10.2217/npy.12.36
Tandon N, Shah J, Keshavan MS, Tandon R. Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. Neuropsychiatry (London). 2012;2(4):345-353. doi: 10.2217/npy.12.36. PMID: 23125875; PMCID: PMC3483069.
Copy Download .nbib Format: NLM
Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders.

Neuropsychiatry

Obregon D, Parker-Athill EC, Tan J, Murphy T.
PMID: 23148142
Neuropsychiatry (London). 2012 Aug;2(4):331-343. doi: 10.2217/npy.12.41.

Antimicrobial compounds and psychotropic medications often share overlapping mechanisms of actions and pharmacological effects. The immune system appears to be an important site of interaction as several antimicrobials display neurological and, at times, direct psychotropic effects, while psychotropics have...

Cite
Obregon D, Parker-Athill EC, Tan J, et al. Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders. Neuropsychiatry (London). 2012;2(4):331-343doi: 10.2217/npy.12.41.
Obregon, D., Parker-Athill, E. C., Tan, J., & Murphy, T. (2012). Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders. Neuropsychiatry, 2(4), 331-343. https://doi.org/10.2217/npy.12.41
Obregon, Demian, et al. "Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders." Neuropsychiatry vol. 2,4 (2012): 331-343. doi: https://doi.org/10.2217/npy.12.41
Obregon D, Parker-Athill EC, Tan J, Murphy T. Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders. Neuropsychiatry (London). 2012 Aug;2(4):331-343. doi: 10.2217/npy.12.41. PMID: 23148142; PMCID: PMC3494283.
Copy Download .nbib Format: NLM
Current electroconvulsive therapy practice and research in the geriatric population.

Neuropsychiatry

Kerner N, Prudic J.
PMID: 24778709
Neuropsychiatry (London). 2014 Feb;4(1):33-54. doi: 10.2217/npy.14.3.

Electroconvulsive therapy (ECT) is utilized worldwide for various severe and treatment-resistant psychiatric disorders. Research studies have shown that ECT is the most effective and rapid treatment available for elderly patients with depression, bipolar disorder and psychosis. For patients who...

Cite
Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London). 2014;4(1):33-54doi: 10.2217/npy.14.3.
Kerner, N., & Prudic, J. (2014). Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry, 4(1), 33-54. https://doi.org/10.2217/npy.14.3
Kerner, Nancy, and Prudic, Joan. "Current electroconvulsive therapy practice and research in the geriatric population." Neuropsychiatry vol. 4,1 (2014): 33-54. doi: https://doi.org/10.2217/npy.14.3
Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London). 2014 Feb;4(1):33-54. doi: 10.2217/npy.14.3. PMID: 24778709; PMCID: PMC4000084.
Copy Download .nbib Format: NLM
Personalizing behavioral interventions: the case of late-life depression.

Neuropsychiatry

Arean PA.
PMID: 23646065
Neuropsychiatry (London). 2012 Apr;2(2):135-145. doi: 10.2217/npy.12.15.

This article reviews the potential utility of behavioral interventions in personalized depression treatment. The paper begins with a definition of personalized treatment, moves to current thinking regarding the various causes of depression, and proposes how those causes can be...

Cite
Arean PA. Personalizing behavioral interventions: the case of late-life depression. Neuropsychiatry (London). 2012;2(2):135-145doi: 10.2217/npy.12.15.
Arean, P. A. (2012). Personalizing behavioral interventions: the case of late-life depression. Neuropsychiatry, 2(2), 135-145. https://doi.org/10.2217/npy.12.15
Arean, Patricia A. "Personalizing behavioral interventions: the case of late-life depression." Neuropsychiatry vol. 2,2 (2012): 135-145. doi: https://doi.org/10.2217/npy.12.15
Arean PA. Personalizing behavioral interventions: the case of late-life depression. Neuropsychiatry (London). 2012 Apr;2(2):135-145. doi: 10.2217/npy.12.15. PMID: 23646065; PMCID: PMC3643295.
Copy Download .nbib Format: NLM
Substance-use disorders in adolescents and adults with ADHD: focus on treatment.

Neuropsychiatry

Wilens TE, Morrison NR.
PMID: 23105949
Neuropsychiatry (London). 2012 Aug;2(4):301-312. doi: 10.2217/npy.12.39.

A high prevalence of comorbidity of ADHD and substance-use disorders (SUDs) has been shown in the literature. In this article, the literature for the treatment of adolescents and adults with co-occurring ADHD and SUD is examined. Findings from pharmacotherapy...

Cite
Wilens TE, Morrison NR. Substance-use disorders in adolescents and adults with ADHD: focus on treatment. Neuropsychiatry (London). 2012;2(4):301-312doi: 10.2217/npy.12.39.
Wilens, T. E., & Morrison, N. R. (2012). Substance-use disorders in adolescents and adults with ADHD: focus on treatment. Neuropsychiatry, 2(4), 301-312. https://doi.org/10.2217/npy.12.39
Wilens, Timothy E, and Morrison, Nicholas R. "Substance-use disorders in adolescents and adults with ADHD: focus on treatment." Neuropsychiatry vol. 2,4 (2012): 301-312. doi: https://doi.org/10.2217/npy.12.39
Wilens TE, Morrison NR. Substance-use disorders in adolescents and adults with ADHD: focus on treatment. Neuropsychiatry (London). 2012 Aug;2(4):301-312. doi: 10.2217/npy.12.39. PMID: 23105949; PMCID: PMC3480177.
Copy Download .nbib Format: NLM
Treatment of comorbid anxiety and autism spectrum disorders.

Neuropsychiatry

Nadeau J, Sulkowski ML, Ung D, Wood JJ, Lewin AB, Murphy TK, May JE, Storch EA.
PMID: 24174992
Neuropsychiatry (London). 2011 Dec;1(6):567-578. doi: 10.2217/npy.11.62.

Clinically significant anxiety occurs frequently among individuals with autism spectrum disorders (ASDs) and is linked to increased psychosocial, familial, behavioral and academic impairment beyond the core autism symptoms when present. Although efforts are underway to establish empirically supported treatments...

Cite
Nadeau J, Sulkowski ML, Ung D, et al. Treatment of comorbid anxiety and autism spectrum disorders. Neuropsychiatry (London). 2011;1(6):567-578doi: 10.2217/npy.11.62.
Nadeau, J., Sulkowski, M. L., Ung, D., Wood, J. J., Lewin, A. B., Murphy, T. K., May, J. E., & Storch, E. A. (2011). Treatment of comorbid anxiety and autism spectrum disorders. Neuropsychiatry, 1(6), 567-578. https://doi.org/10.2217/npy.11.62
Nadeau, Joshua, et al. "Treatment of comorbid anxiety and autism spectrum disorders." Neuropsychiatry vol. 1,6 (2011): 567-578. doi: https://doi.org/10.2217/npy.11.62
Nadeau J, Sulkowski ML, Ung D, Wood JJ, Lewin AB, Murphy TK, May JE, Storch EA. Treatment of comorbid anxiety and autism spectrum disorders. Neuropsychiatry (London). 2011 Dec;1(6):567-578. doi: 10.2217/npy.11.62. PMID: 24174992; PMCID: PMC3809000.
Copy Download .nbib Format: NLM
Altered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer Patients.

Neuropsychiatry

Saligan LN, Lukkahatai N, Zhang ZJ, Cheung CW, Wang XM.
PMID: 30364895
Neuropsychiatry (London). 2018;8(4):1249-1262. doi: 10.4172/Neuropsychiatry.1000454.

Fatigue, the most common side effect of cancer treatments, is observed to intensify during external-beam radiation therapy (EBRT). The underlying molecular mechanisms remain unclear. This study investigated the differentially expressed genes/proteins and their association with fatigue intensification during EBRT....

Cite
Saligan LN, Lukkahatai N, Zhang ZJ, et al. Altered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer Patients. Neuropsychiatry (London). 2018;8(4):1249-1262doi: 10.4172/Neuropsychiatry.1000454.
Saligan, L. N., Lukkahatai, N., Zhang, Z. J., Cheung, C. W., & Wang, X. M. (2018). Altered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer Patients. Neuropsychiatry, 8(4), 1249-1262. https://doi.org/10.4172/Neuropsychiatry.1000454
Saligan, Leorey N, et al. "Altered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer Patients." Neuropsychiatry vol. 8,4 (2018): 1249-1262. doi: https://doi.org/10.4172/Neuropsychiatry.1000454
Saligan LN, Lukkahatai N, Zhang ZJ, Cheung CW, Wang XM. Altered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer Patients. Neuropsychiatry (London). 2018;8(4):1249-1262. doi: 10.4172/Neuropsychiatry.1000454. PMID: 30364895; PMCID: PMC6198670.
Copy Download .nbib Format: NLM
Impulse control disorders in Parkinson's disease: clinical characteristics and implications.

Neuropsychiatry

Leeman RF, Potenza MN.
PMID: 21709778
Neuropsychiatry (London). 2011 Apr;1(2):133-147. doi: 10.2217/npy.11.11.

Impulse control disorders (ICDs), specifically those related to excessive gambling, eating, sex and shopping, have been observed in a subset of people with Parkinson's disease (PD). Although some initial case reports claimed that dopamine replacement therapies, particularly dopamine agonists,...

Cite
Leeman RF, Potenza MN. Impulse control disorders in Parkinson's disease: clinical characteristics and implications. Neuropsychiatry (London). 2011;1(2):133-147doi: 10.2217/npy.11.11.
Leeman, R. F., & Potenza, M. N. (2011). Impulse control disorders in Parkinson's disease: clinical characteristics and implications. Neuropsychiatry, 1(2), 133-147. https://doi.org/10.2217/npy.11.11
Leeman, Robert F, and Potenza, Marc N. "Impulse control disorders in Parkinson's disease: clinical characteristics and implications." Neuropsychiatry vol. 1,2 (2011): 133-147. doi: https://doi.org/10.2217/npy.11.11
Leeman RF, Potenza MN. Impulse control disorders in Parkinson's disease: clinical characteristics and implications. Neuropsychiatry (London). 2011 Apr;1(2):133-147. doi: 10.2217/npy.11.11. PMID: 21709778; PMCID: PMC3120055.
Copy Download .nbib Format: NLM
Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy.

Neuropsychiatry

Gonzalez-Heydrich J, Hamoda HM, Luna L, Rao S, McClendon J, Rotella P, Waber D, Boyer K, Faraone SV, Whitney J, Guild D, Biederman J.
PMID: 23397446
Neuropsychiatry (London). 2012 Oct 01;2(5):385-391. doi: 10.2217/npy.12.53.

OBJECTIVES: To describe the prevalence of ADHD in mothers of children with comorbid ADHD and epilepsy (ADHD+E) and to compare ADHD symptoms in mothers with (Fam(+)) and without (Fam(-)) additional relative(s) with epilepsy. PATIENTS & METHODS: Mothers (n =...

Cite
Gonzalez-Heydrich J, Hamoda HM, Luna L, et al. Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy. Neuropsychiatry (London). 2012;2(5):385-391doi: 10.2217/npy.12.53.
Gonzalez-Heydrich, J., Hamoda, H. M., Luna, L., Rao, S., McClendon, J., Rotella, P., Waber, D., Boyer, K., Faraone, S. V., Whitney, J., Guild, D., & Biederman, J. (2012). Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy. Neuropsychiatry, 2(5), 385-391. https://doi.org/10.2217/npy.12.53
Gonzalez-Heydrich, Joseph, et al. "Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy." Neuropsychiatry vol. 2,5 (2012): 385-391. doi: https://doi.org/10.2217/npy.12.53
Gonzalez-Heydrich J, Hamoda HM, Luna L, Rao S, McClendon J, Rotella P, Waber D, Boyer K, Faraone SV, Whitney J, Guild D, Biederman J. Elevated rates of ADHD in mothers of children with comorbid ADHD and epilepsy. Neuropsychiatry (London). 2012 Oct 01;2(5):385-391. doi: 10.2217/npy.12.53. PMID: 23397446; PMCID: PMC3565178.
Copy Download .nbib Format: NLM
Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders.

Neuropsychiatry

Bearss K, Lecavalier L, Minshawi N, Johnson C, Smith T, Handen B, Sukhodolsky D, Aman M, Swiezy N, Butter E, Scahill L.
PMID: 23772233
Neuropsychiatry (London). 2013 Apr;3(2):169-180. doi: 10.2217/npy.13.14.

Autism spectrum disorders (ASD) are chronic conditions of early childhood onset characterized by profound deficits in social interaction, impaired communication, and repetitive behavior. The prevalence of ASD is now estimated to be 1 in 88 children. As the number...

Cite
Bearss K, Lecavalier L, Minshawi N, et al. Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders. Neuropsychiatry (London). 2013;3(2):169-180doi: 10.2217/npy.13.14.
Bearss, K., Lecavalier, L., Minshawi, N., Johnson, C., Smith, T., Handen, B., Sukhodolsky, D., Aman, M., Swiezy, N., Butter, E., & Scahill, L. (2013). Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders. Neuropsychiatry, 3(2), 169-180. https://doi.org/10.2217/npy.13.14
Bearss, Karen, et al. "Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders." Neuropsychiatry vol. 3,2 (2013): 169-180. doi: https://doi.org/10.2217/npy.13.14
Bearss K, Lecavalier L, Minshawi N, Johnson C, Smith T, Handen B, Sukhodolsky D, Aman M, Swiezy N, Butter E, Scahill L. Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders. Neuropsychiatry (London). 2013 Apr;3(2):169-180. doi: 10.2217/npy.13.14. PMID: 23772233; PMCID: PMC3678377.
Copy Download .nbib Format: NLM
Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorder.

Neuropsychiatry

Goodkin K, Alger JR, Maudsley AA, Govind V, Sheriff S, Zhang JM.
PMID: 23682297
Neuropsychiatry (London). 2012 Oct 01;2(5):379-383. doi: 10.2217/npy.12.50.

No abstract available.

Cite
Goodkin K, Alger JR, Maudsley AA, et al. Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorder. Neuropsychiatry (London). 2012;2(5):379-383doi: 10.2217/npy.12.50.
Goodkin, K., Alger, J. R., Maudsley, A. A., Govind, V., Sheriff, S., & Zhang, J. M. (2012). Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorder. Neuropsychiatry, 2(5), 379-383. https://doi.org/10.2217/npy.12.50
Goodkin, Karl, et al. "Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorder." Neuropsychiatry vol. 2,5 (2012): 379-383. doi: https://doi.org/10.2217/npy.12.50
Goodkin K, Alger JR, Maudsley AA, Govind V, Sheriff S, Zhang JM. Clinical utility of magnetic resonance spectroscopy to enhance diagnosis of HIV-associated mild neurocognitive disorder. Neuropsychiatry (London). 2012 Oct 01;2(5):379-383. doi: 10.2217/npy.12.50. PMID: 23682297; PMCID: PMC3652484.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries